NCT02861417 2026-02-17Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantM.D. Anderson Cancer CenterPhase 2 Active not recruiting204 enrolled